Hospital Acquired MRSA: Are We Aggressive Enough?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Hospital Acquired MRSA has gone from 40% to 60% in ten years. Dr. Shira Johnson interviews Dr. Donald Goldmann from the Institute for Healthcare Improvement to discuss our approach to this pathogen. Why aren't we successful in eradicating MRSA in our hospitals?
Overview
Hospital Acquired MRSA has gone from 40% to 60% in ten years. Dr. Shira Johnson interviews Dr. Donald Goldmann from the Institute for Healthcare Improvement to discuss our approach to this pathogen. Why aren't we successful in eradicating MRSA in our hospitals?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Love Story: Lipid Education for Women’s Heart Health
Personalizing Care Within the RCC Treatment Paradigm
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?